Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | PYGL | P06737 | 1/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.30 |
| ▸ | PPM1A | P35813 | 1/20 | 0.30 |
| ▸ | MIF | P14174 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25878282 | 0.82 | CYP4F2 (0.33) | CYP4F2CYP4A11NR3C1EPAS1MEN1 | |
| SCHEMBL24075154 | 0.78 | P2RX7 (0.30) | — | |
| SCHEMBL13131958 | 0.76 | KDM4E (0.36) | CYP4F2CYP4A11KCNH2TMEM97SIGMAR1 | |
| SCHEMBL25877357 | 0.76 | NR3C1 (0.31) | NR3C1 | |
| SCHEMBL12711141 | 0.76 | KDM4E (0.42) | KCNH2 | |
| SCHEMBL24074821 | 0.73 | PARP1 (0.42) | MEN1KMT2A | |
| SCHEMBL24075153 | 0.72 | GNRHR (0.31) | — | |
| SCHEMBL12711134 | 0.71 | GRM2 (0.42) | GRM2 | |
| SCHEMBL24073863 | 0.71 | MEN1 (0.36) | MEN1KMT2AGRM2 | |
| SCHEMBL18355880 | 0.69 | CYP4F2 (0.57) | CYP4F2CYP4A11EPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022129333-A1 | BRANCHED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 | JANSSEN PHARMACEUTICA NV (BE) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022008674-A1 | MACROCYCLIC ETHER CONTAINING INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 | JANSSEN PHARMACEUTICA NV (BE) | 2022-01-13 | — | — | WO | disclosed |
| WO-2021255257-A1 | N-LINKED MACROCYCLIC 7-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 | JANSSEN PHARMACEUTICA NV (BE) | 2021-12-23 | — | — | WO | disclosed |
| WO-2021255258-A1 | N-LINKED MACROCYCLIC 4-(PYRAZOL-5-YL)-INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 | JANSSEN PHARMACEUTICA NV (BE) | 2021-12-23 | — | — | WO | disclosed |